Targeting a Moving Threshold: Antigen Density as a Design Constraint for Particulate Drug Delivery in HER2-Low and HER2-Ultralow Breast Cancer-A Narrative Review.

Sescu VA, Filipescu A, Solomon Condriuc IP, Burac M, Scripcariu IS, Socolov D, Socolov R, Cărăuleanu A

Open source

DOI
10.3390/pharmaceutics18101218
Published
2026 Sep 25
Container
Pharmaceutics
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/pharmaceutics18101218,
  title = {Targeting a Moving Threshold: Antigen Density as a Design Constraint for Particulate Drug Delivery in HER2-Low and HER2-Ultralow Breast Cancer-A Narrative Review.},
  author = {Sescu VA and Filipescu A and Solomon Condriuc IP and Burac M and Scripcariu IS and Socolov D and Socolov R and Cărăuleanu A},
  year = {2026},
  journal = {Pharmaceutics},
  doi = {10.3390/pharmaceutics18101218},
  url = {https://doi.org/10.3390/pharmaceutics18101218}
}

RIS

TY  - JOUR
TI  - Targeting a Moving Threshold: Antigen Density as a Design Constraint for Particulate Drug Delivery in HER2-Low and HER2-Ultralow Breast Cancer-A Narrative Review.
AU  - Sescu VA
AU  - Filipescu A
AU  - Solomon Condriuc IP
AU  - Burac M
AU  - Scripcariu IS
AU  - Socolov D
AU  - Socolov R
AU  - Cărăuleanu A
PY  - 2026
JO  - Pharmaceutics
DO  - 10.3390/pharmaceutics18101218
UR  - https://doi.org/10.3390/pharmaceutics18101218
ER  - 

APA

VA, S., A, F., IP, S. C., M, B., IS, S., D, S., R, S., & A, C. (2026). Targeting a Moving Threshold: Antigen Density as a Design Constraint for Particulate Drug Delivery in HER2-Low and HER2-Ultralow Breast Cancer-A Narrative Review.. Pharmaceutics. https://doi.org/10.3390/pharmaceutics18101218

Source records